People In Brief

Hassan joins B&L board: Former Schering-Plough CEO Fred Hassan brings extensive experience in corporate and trade group leadership to the board of Rochester, N.Y.-based vision care product firm Bausch & Lomb, according to a Nov. 12 release. Hassan became Schering's CEO in 2003, leading the firm as it revived its allergy business following the first-in-category OTC switch of the Claritin (loratadine) allergy drug in December 2002, and continued there until Merck acquired the firm in a deal that closed Nov. 3. He also was CEO at Pharmacia Corp. from 2001 to 2003, when it was acquired by Pfizer. Hassan has held senior posts in the pharmaceutical industry since 1972 and has headed the Pharmaceutical Research and Manufacturers of America and the International Federation of Pharmaceutical Manufacturers Associations